New Jersey: NJPMP checks required

UnitedHealthcare Community Plan of New Jersey health care professionals writing prescriptions must check the New Jersey Prescription Monitoring Program (NJPMP) database when prescribing and/or dispensing controlled dangerous substances (CDS) to members.

What’s required

The Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act requires states to maintain a qualified prescription drug monitoring program (PDMP). UnitedHealthcare network care providers are required to obtain information from the PDMP prior to prescribing controlled substances.

What this means for you

You must comply with the laws and regulations governing the NJPMP.

Resources

For more information, please see the following:

• Chapter 45A Subchapter 35 Prescription Monitoring Program Regulations
• NJPMP statutes 
• njmmis.com > Newsletters & Alerts > Type in volume 33 and number 16 to see the newsletter titled Compliance with the SUPPORT Act and requirements to utilize the New Jersey Prescription Monitoring Program (NJPMP) prior to prescribing and dispensing Controlled Dangerous Substances (CDS) for Medicaid/NJ Family Care members

PCA-1-24-02243-Clinical-NN_08012024